Joseph Salois, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1555 W Us Highway 54, Vandalia, MO 63382 Phone: 573-594-2136 |
News Archive
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate galeterone (TOK-001) was well-tolerated with minimal side effects and demonstrated efficacy in patients with castration-resistant prostate cancer (CRPC) in a Phase 1 study.
A large-scale implementation of a protocol to improve recovery of patients after weight-loss operations was found to reduce rates of extended hospitalization by almost half at 36 participating accredited bariatric surgery centers nationwide, according to a study published online ahead of print in the current issue of the journal Surgery for Obesity and Related Diseases.
Allegedly, they should not exist in the brain, the so-called precapillary sphincters - a kind of squeezing 'muscle clamp' between the larger and smaller vessels of the bloodstream.
Recent advances in the understanding of cancer have led to more personalized therapies, such as drugs that target particular proteins and tests that analyze gene expression patterns in tumors to predict a patient's response to therapy.
› Verified 9 days ago